Trial intelligence / Profile preview

Phase 3 confirmatory study of glumetinib in MET exon 14 skipping advanced non-small cell lung cancer

CTR20231712Phase 3Active

Sponsor

Haihe

Start

Oct 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1